Osteonecrosis of the knee

1. High-Yield Summary

• Distinct Pathologic Entities: Osteonecrosis of the knee encompasses two distinct conditions with fundamentally different etiologies: Spontaneous Osteonecrosis of the Knee (SPONK), now recognized as a Subchondral Insufficiency Fracture of the Knee (SIFK), and Secondary Osteonecrosis of the Knee (Secondary ONK) resulting from systemic ischemia, corticosteroid excess, alcohol abuse, or hemoglobinopathies.
• Demographics and Clinical Presentation: SPONK typically presents in women older than 60 years with acute, sudden-onset, severe medial joint-line pain without antecedent trauma, while Secondary ONK presents in younger patients (20 to 50 years) with insidious, bilateral (greater than 80%), deep-seated aching pain and multifocal joint involvement.
• Biomechanical Driver of SPONK: SIFK/SPONK is strongly correlated with posterior root tears of the medial meniscus (MMPRT). Extrusion of the medial meniscus abolishes circumferential hoop stresses and concentrates physiological contact loads onto osteopenic subchondral bone, precipitating microtrabecular fracture and localized ischemic collapse.
• Prognostic Thresholds: The Lotke radiographic index determines prognosis: lesion area less than 3.5 cm² (or less than 33% of condylar width) carries a favorable prognosis with nonoperative offloading, whereas lesions greater than 5.0 cm² (or greater than 50% of condylar width) invariably progress to subchondral collapse and secondary degenerative osteoarthritis.
• Surgical Reconstruction Hierarchy: Pre-collapse disease can be treated with protected weightbearing, pharmacotherapy, core decompression, or high tibial osteotomy (HTO). Post-collapse SPONK confined to the medial compartment is ideally managed with unicompartmental knee arthroplasty (UKA), achieving greater than 94% 10-year survivorship, whereas Secondary ONK mandates total knee arthroplasty (TKA), frequently requiring stem extensions due to diffuse metaphyseal bone involvement.

2. Anatomy

Surgical management of osteonecrosis of the knee requires a comprehensive understanding of the distal femoral and proximal tibial vascular architecture, surgical internervous planes, and critical neurovascular structures adjacent to the joint line.

Vascular Supply of the Distal Femur and Proximal Tibia:

• Distal Femoral Genicular Network: The distal femur receives its vascular supply through the genicular arterial anastomotic ring, composed of the descending genicular artery (originating from the superficial femoral artery), superior medial and lateral genicular arteries, and inferior medial and lateral genicular arteries (branches of the popliteal artery). The middle genicular artery penetrates the posterior capsule to supply the cruciate ligaments and intercondylar notch.
• Terminal Medial Condylar Epiphyseal Supply: The epiphyseal circulation of the medial femoral condyle (MFC) is terminal with minimal trans-subchondral collateral flow. An intraosseous watershed zone exists at the central and anterior weightbearing articular dome of the MFC. Disruption of these terminal arterioles by microtrabecular fracture or microthrombosis isolates the subchondral bone plate, explaining why the MFC accounts for approximately 90% of spontaneous osteonecrosis cases.
• Proximal Tibial Supply: The proximal tibia is vascularized by the anterior and posterior tibial recurrent arteries and the inferior genicular vessels entering through the periosteum and capsuloligamentous insertions. The medial tibial plateau possesses a richer collateral network than the distal femur, making tibial SIFK less prone to extensive avascular collapse.

Surgical Approaches and Internervous Planes:

• Medial Parapatellar Approach: The standard workhorse approach for TKA and medial UKA. The incision traverses the skin, subcutaneous tissue, medial retinaculum, and quadriceps tendon, continuing distally along the medial border of the patellar tendon. There is no true intermuscular internervous plane because the quadriceps musculature is innervated entirely by branches of the femoral nerve; exposure relies on mobilizing the extensor mechanism.
• Medial Opening Wedge High Tibial Osteotomy Exposure: Developed along the anteromedial proximal tibia between the superficial medial collateral ligament (sMCL) and the pes anserinus tendons (gracilis, sartorius, semitendinosus). The sMCL is elevated subperiosteally to expose the posteromedial cortex.
• Lateral Closing Wedge High Tibial Osteotomy Exposure: Utilizes the internervous plane between the anterior compartment muscles (tibialis anterior and extensor digitorum longus, innervated by the deep peroneal nerve) and the lateral compartment muscles (peroneus longus and brevis, innervated by the superficial peroneal nerve).

Neurovascular Danger Zones:

• Popliteal Neurovascular Bundle: The popliteal artery and tibial nerve reside directly posterior to the central posterior joint capsule and posterior cruciate ligament (PCL) tibial attachment. In full extension, the popliteal artery lies within 7 to 8 mm of the posterior tibial cortex. Flexing the knee to 90 degrees displaces the artery posteriorly by several millimeters. During tibial resection or osteotomy, a dedicated Hohmann or bent retractor must be positioned subperiosteally directly on bone to shield the vascular bundle.
• Common Peroneal Nerve: Encircles the fibular neck approximately 1.5 to 2.0 cm distal to the styloid process of the fibular head. It is at substantial risk during lateral closing wedge HTO, lateral core decompression, and proximal fibular osteotomy. Careful subperiosteal exposure and avoidance of excessive posterior retraction are mandatory.
• Infrapatellar Branch of the Saphenous Nerve (IPBSN): Arises from the saphenous nerve in Hunter’s canal and crosses transversely over the anteromedial proximal tibia. Longitudinal medial incisions divide this branch in up to 70% of cases, risking painful neuroma formation or anterolateral hypesthesia.

3. Pathogenesis

The pathogenesis of knee osteonecrosis is categorized into three distinct mechanical and biological pathways: mechanical subchondral fatigue (SPONK/SIFK), systemic microvascular compromise (Secondary ONK), and post-arthroscopic osteonecrosis.

Spontaneous Osteonecrosis of the Knee / Subchondral Insufficiency Fracture (SPONK/SIFK):

• Mechanical Failure Model: Although historically considered a primary ischemic infarction, contemporary histology and advanced imaging demonstrate that SPONK is primarily an insufficiency fracture of the subchondral trabecular bone in osteopenic elderly bone subjected to repetitive physiological loading.
• Meniscal Root Breakdown: Posterior root tears of the medial meniscus (MMPRT) are present in 70% to 80% of SPONK cases. Root avulsion eliminates circumferential hoop stress conversion, causing pathological meniscal extrusion (greater than 3 mm). This shifts contact stresses directly onto the articular cartilage and subchondral bone of the medial femoral condyle, increasing peak local contact pressures by 300% to 400%.
• Ischemic Cascade: The concentrated stress exceeds the yield strength of the osteopenic subchondral bone, causing microtrabecular fracture. Microfracture shears terminal microvessels, leading to focal secondary ischemic necrosis of the detached subchondral bone segment. Concomitant microcracks in the calcified cartilage layer allow synovial fluid ingress under joint pressure, triggering intense bone marrow edema, elevated intraosseous pressure, localized nonunion, and ultimate subchondral collapse.

Secondary Osteonecrosis of the Knee (Secondary ONK):

• Corticosteroid-Induced Marrow Lipocyte Hypertrophy: Glucocorticoid exposure (systemic doses exceeding 2,000 mg prednisone equivalent or daily doses exceeding 20 mg) causes pluripotent mesenchymal stem cells to preferentially differentiate into adipocytes. Marrow fat cell hypertrophy increases the volume of marrow fat within a rigid, non-distensible bony compartment.
• Intravascular Thrombosis and Sinusoidal Stasis: Elevated intraosseous pressure compresses thin-walled medullary sinusoids, resulting in venous stasis, retrograde ischemia, endothelial injury, and intravascular microthrombosis. Hyperlipidemia and circulating fat microemboli further occlude terminal microvessels.
• Systemic Comorbidities: Alcohol abuse induces fatty liver transformation, hyperlipidemia, and fat embolization. Sickle cell disease and hemoglobinopathies cause erythrocyte sickling, blood hyperviscosity, and mechanical capillary occlusion. Systemic lupus erythematosus (SLE) induces immune-complex vasculitis and antiphospholipid-mediated thrombosis. Gaucher disease causes marrow infiltration by glucocerebroside-laden histiocytes that physically compress medullary vessels.

Post-Arthroscopic Osteonecrosis:

• Iatrogenic Destabilization and Thermal Injury: Rapid osteonecrosis can develop following arthroscopic partial meniscectomy, aggressive subchondral chondroplasty, or the use of radiofrequency ablation devices. Meniscal resection unmasks latent mechanical insufficiency, while excessive thermal energy induces direct osteocyte necrosis in vulnerable subchondral bone.

4. Natural History

The natural history and clinical course of osteonecrosis of the knee differ substantially depending on the underlying etiology and the size of the lesion at presentation.

Epidemiology and Anatomic Predilection:

• SPONK Demographics: Typically affects patients older than 60 years, with a female-to-male ratio of approximately 3:1. Involvement is strictly unilateral in greater than 95% of patients. Anatomic distribution: Medial femoral condyle accounts for 85% to 90% of cases, medial tibial plateau represents 8% to 10%, and the lateral femoral condyle occurs in less than 2%.
• Secondary ONK Demographics: Affects younger patients, typically between 20 and 50 years of age. Sex distribution reflects the underlying disease (female predominance in SLE, male predominance in alcoholism). Involvement is bilateral in 80% to 90% of patients and frequently multifocal, with concurrent femoral head or humeral head osteonecrosis present in greater than 70% of individuals. Secondary ONK affects both femoral condyles and the tibial plateau, frequently extending into the metaphysis and diaphysis.

Prognostic Determination: The Lotke Criteria:

• Small Lesions (Area less than 3.5 cm² or width less than 33% of the condyle): Characterized by an excellent prognosis. With protected weightbearing, over 80% of these lesions stabilize, revascularize, and achieve clinical resolution without articular collapse.
• Medium Lesions (Area 3.5 to 5.0 cm² or width 33% to 50% of the condyle): Intermediate prognosis. Approximately 50% progress to subchondral fracture, condylar flattening, and degenerative arthritis, requiring surgical intervention.
• Large Lesions (Area greater than 5.0 cm² or width greater than 50% of the condyle): Invariably poor prognosis. Over 85% progress rapidly to subchondral fracture, articular collapse, joint space obliteration, and secondary tricompartmental osteoarthritis within 1 to 2 years if left untreated.

5. Clinical Presentation

History

The patient history provides immediate clues to differentiate SPONK from Secondary ONK:

• SPONK / SIFK Presentation: Patients recount a sudden, abrupt onset of severe, sharp, unicompartmental knee pain, often pinpointing the exact hour of onset during an ordinary low-demand movement (such as stepping off a curb, rising from a chair, or walking). Severe resting pain and night pain waking the patient from sleep are classic features. Weightbearing is acutely painful or impossible without support. Mechanical symptoms (clicking, locking) are uncommon initially, but antalgic gait is pronounced.
• Secondary ONK Presentation: Symptoms develop insidiously over weeks to months as a dull, deep-seated ache poorly localized to the knee or distal thigh. Pain is progressive, bilateral, aggravated by weightbearing, and moderately relieved by rest in early stages. Clinicians must specifically inquire about high-dose or prolonged corticosteroid use, chemotherapy, organ transplantation, autoimmune conditions, heavy alcohol intake, and sickle cell disease.

Physical Exam

A systematic, step-by-step physical examination is essential to localize pathology, assess joint stability, and identify concomitant meniscal or ligamentous lesions:

• Medial Condylar Percussion Test: Direct percussion over the exposed medial femoral condyle with the knee flexed to 90 degrees -> Sharp, focal periosteal and subchondral pain [Sensitivity 88%, Specificity 84%]. This distinguishes condylar bone pathology from superficial soft tissue pain.
• Joint Line Tenderness Palpation: Palpation along the medial joint line -> Positive localized tenderness [Sensitivity 75%, Specificity 62%]. Tenderness of SPONK is typically centered slightly proximal to the joint line over the condyle rather than strictly within the meniscotibial sulcus.
• McMurray Test: Knee flexed, externally rotated, and brought into extension with valgus stress -> Pain or palpable pop [Sensitivity 65%, Specificity 72%]. Frequently positive due to concomitant medial meniscus posterior horn or root tears.
• Medial Meniscal Root Extrusion Sign: Firm palpation along the anteromedial joint margin during axial loading or weightbearing -> Palpable radial extrusion of the meniscal body beyond the tibial plateau margin [Sensitivity 82%, Specificity 88%].
• Effusion Assessment: Ballottement or fluid wave test -> Mild to moderate non-inflammatory joint effusion [Sensitivity 80%, Specificity 58%]. Tense effusions are rare unless secondary mechanical cartilage breakdown has ensued.
• Alignment and Gait Evaluation: Observation of gait shows an antalgic limp with shortened stance phase. In advanced stages with condylar collapse, a dynamic varus thrust may be observed during early stance.

6. Imaging and Diagnostic Studies

Early identification requires an organized diagnostic hierarchy, advancing from baseline radiographs to magnetic resonance imaging, which serves as the gold standard.

Radiographic Evaluation:

• Standard Series: Standing anteroposterior (AP), true lateral, 45-degree flexion weightbearing posteroanterior (Rosenberg view), and axial patellofemoral (Merchant) views. Full-length bilateral weightbearing mechanical axis radiographs are mandatory when planning osteotomy or arthroplasty.
• Early Radiographic Findings: Plain radiographs are completely normal in early disease (Koshino Stage I / Mont Stage I) despite severe clinical symptoms. A normal radiograph in an elderly patient with acute severe knee pain must prompt an urgent MRI.
• Evolving Radiographic Signs: Progression reveals a subchondral radiolucent crescent line (pathognomonic fracture of the subchondral bone plate), flattening of the weightbearing articular contour of the medial femoral condyle, a radiolucent necrotic lesion surrounded by a sclerotic halo of reactive bone formation, progressive articular step-off, subchondral collapse, joint space narrowing, and secondary osteophytosis.

Magnetic Resonance Imaging (MRI) – Gold Standard:

• T1-Weighted Sequences: Reveal a discrete, low-signal intensity line convex toward the articular surface representing the subchondral insufficiency fracture or necrotic interface. The surrounding marrow shows ill-defined low-intensity edema replacing normal fatty marrow signal.
• T2-Weighted / STIR / PDFS Sequences: Show intense, extensive hyperintense bone marrow lesion (BML) edema extending from the subchondral bone into the epiphysis and metaphysis. A focal fluid-signal line beneath the subchondral bone plate indicates structural delamination and impending articular collapse.
• Secondary ONK Imaging Hallmarks: Demonstrates a classic “double-line sign” on T2-weighted imaging, characterized by an outer hypointense serpentine rim of reactive sclerotic bone and an inner hyperintense rim of vascularized granulation tissue. Lesions are frequently multifocal, geographic, and involve both femoral condyles and metaphyses.
• Meniscal Assessment: MRI reliably detects medial meniscus posterior root tears (radial cut within 9 mm of insertion, “ghost sign” on sagittal cuts) and quantitative meniscal extrusion exceeding 3 mm.

Computed Tomography (CT):

• Submillimeter multiplanar CT accurately quantifies articular collapse depth (in millimeters), cortical step-off, subchondral cyst formation, and posterior condylar extension, which is crucial for determining bone preservation feasibility versus arthroplasty component selection.

Radionuclide Bone Scintigraphy (Technetium-99m):

• Useful when MRI is contraindicated. Shows intense, focal tracer uptake (“hot spot”) in the affected condyle on blood-pool and delayed phases. In Secondary ONK, bone scans may show central photopenic (“cold”) defects surrounded by hyperactive reactive margins.

7. Classification

Classification systems for knee osteonecrosis stratify disease by etiology, radiographic progression, and structural integrity of the subchondral plate to guide clinical decision-making.

Koshino Radiographic Staging System for SPONK:

Mont / Ficat & Arlet Classification for Secondary Osteonecrosis:

8. Treatment

Medical / Nonoperative

Nonoperative management is the primary treatment for pre-collapse SPONK (Koshino Stage I and II) with a Lotke lesion area less than 3.5 cm², as well as early asymptomatic Secondary ONK.

• Protected Weightbearing: Touch-down or non-weightbearing with crutches or a walker for 6 to 12 weeks. Eliminating axial impact prevents microtrabecular fracture propagation and subchondral depression while native revascularization and bone remodeling proceed.
• Unloader Bracing: A pneumatic or rigid valgus unloader knee brace shifts the mechanical axis away from the affected medial femoral condyle toward the lateral compartment, reducing peak contact forces during ambulation.
• Analgesic Pharmacotherapy: Acetaminophen and short courses of nonsteroidal anti-inflammatory drugs (NSAIDs) for acute pain control and reduction of secondary synovitis.
• Bisphosphonate Therapy: Intravenous ibandronate, zoledronic acid, or oral alendronate. Bisphosphonates inhibit osteoclastic bone resorption during the repair phase, preventing premature structural collapse of weakened trabeculae while revascularization occurs.
• Anabolic Bone Therapy: Off-label teriparatide (recombinant PTH 1-34) to accelerate trabecular bone formation and insufficiency fracture healing in elderly osteoporotic patients with SIFK.
• Objective Failure Criteria: Progressive pain after 8 to 12 weeks of nonoperative management, lesion enlargement on surveillance MRI, or radiographic evidence of subchondral collapse (crescent sign, articular depression) warrants transition to surgical intervention.

Operative

Surgical management is dictated by whether the articular surface has collapsed (pre-collapse joint preservation vs post-collapse arthroplasty).

Joint-Preserving Procedures (Pre-Collapse: Koshino I-II, Mont I-II):

• Core Decompression: Percutaneous drilling of the necrotic condyle under fluoroscopic guidance using multiple 3.0 mm to 4.0 mm drill holes or a single 6.0 mm to 8.0 mm trephine. Decompression reduces intraosseous venous hypertension, relieves pain, and creates channels for mesenchymal cell migration and neovascularization. Most effective in Mont Stage I and II Secondary ONK.
• Orthobiologic Augmentation: Core decompression combined with concentrated autologous bone marrow aspirate (BMAC) or demineralized bone matrix (DBM). Delivers osteogenic progenitor cells and angiogenic cytokines directly to the ischemic zone.
• Subchondroplasty: Percutaneous, fluoroscopically guided injection of nanocrystalline calcium phosphate bone substitute directly into the subchondral bone marrow lesion. The cement-like biomaterial provides immediate compressive strength to the fractured trabecular framework and gradually resorbs via osteoclastic remodeling.
• High Tibial Osteotomy (HTO): Indicated in young, physiologically active patients (younger than 60 years) with medial femoral condyle SPONK (Koshino Stage I-III) and constitutional varus malalignment. Medial opening wedge or lateral closing wedge osteotomy shifts the mechanical weightbearing axis into 2 to 4 degrees of anatomical valgus, unloading the diseased condyle and halting structural deterioration.

Arthroplasty Procedures (Post-Collapse: Koshino III-IV, Mont III-V):

• Unicompartmental Knee Arthroplasty (UKA): The gold-standard reconstruction for isolated medial condylar SPONK with subchondral collapse. Requirements: Intact anterior cruciate ligament (ACL), full-thickness cartilage in lateral and patellofemoral compartments, correctable varus deformity, and absence of systemic secondary osteonecrosis. Provides rapid rehabilitation, physiological joint kinematics, bone preservation, and high patient satisfaction.
• Total Knee Arthroplasty (TKA): The treatment of choice for Secondary ONK with articular collapse, large SPONK lesions (Lotke area greater than 5.0 cm²), bicompartmental or tricompartmental involvement, inflammatory arthritis, fixed varus/valgus deformity, or ACL deficiency. In Secondary ONK, extensive metaphyseal bone necrosis frequently requires cemented components with modular stem extensions and metal augments to achieve stable fixation in viable bone.

Indications & Contraindications

• Nonoperative Management Indications: Koshino Stage I or II; Lotke lesion area less than 3.5 cm²; condylar width involvement less than 33%; preserved joint space; absence of subchondral step-off.
• Core Decompression Indications: Pre-collapse Secondary ONK (Mont Stage I or II); failure of nonoperative therapy; absence of articular collapse. Contraindications: Subchondral fracture (crescent sign), articular depression greater than 2 mm, extensive secondary degenerative changes.
• Unicompartmental Knee Arthroplasty Indications: Post-collapse SPONK (Koshino Stage III or IV); isolated medial compartment involvement; intact ACL; flexion contracture less than 5 degrees; correctable varus deformity less than 15 degrees. Absolute Contraindications: Secondary Osteonecrosis (risk of subsequent disease in remaining compartments), inflammatory arthropathy, active infection, cruciate deficiency.
• Total Knee Arthroplasty Indications: Secondary ONK with collapse (Mont Stages III-V); SPONK with lesion area greater than 5.0 cm²; bicompartmental or tricompartmental arthrosis; fixed deformity exceeding 15 degrees; failed prior UKA or HTO.

9. Outcome

Clinical outcomes in knee osteonecrosis depend heavily on etiology, pre-treatment staging, and procedural selection.

• Nonoperative Offloading and Pharmacotherapy: Small pre-collapse SPONK lesions (less than 3.5 cm²) managed with protected weightbearing and bisphosphonate therapy demonstrate resolution of bone marrow edema on MRI and clinical healing in 80% to 85% of cases. Conversely, lesions larger than 5.0 cm² fail conservative care in over 85% of patients, rapidly requiring arthroplasty within 12 to 24 months.
• Core Decompression in Secondary ONK: In pre-collapse stages (Mont Stage I and II), joint preservation success rates range from 72% to 80% at 5- to 10-year follow-up, with marked pain relief and avoidance of arthroplasty. When performed after subchondral collapse (Mont Stage III or higher), failure rates exceed 80%, with rapid conversion to TKA.
• High Tibial Osteotomy: In young, active patients with early-stage medial condylar SPONK and varus alignment, HTO achieves 85% to 88% survivorship at 5 years and 70% to 76% at 10 years, relieving medial contact stresses and promoting fibrocartilaginous remodeling.
• Unicompartmental Knee Arthroplasty in SPONK: UKA yields outstanding long-term results for post-collapse SPONK. Meta-analyses of UKA for SPONK demonstrate a pooled 10-year implant survivorship of 94.2% across multiple international cohorts. Functional scores improve substantially, with Knee Society Knee Scores (KSKS) rising from a preoperative mean of 48-52 to a postoperative mean of 89-94. Notably, revision rates for UKA in SPONK are lower than those for osteoarthritis, because SPONK represents a self-limited focal necrosis without generalized, progressive polygenic cartilage degeneration.
• Total Knee Arthroplasty: In Secondary ONK, 10-year implant survivorship ranges between 88% and 94%. Overall complication and revision rates are higher than in primary osteoarthritis, driven by younger patient age, systemic corticosteroid use, compromised bone density, and medical comorbidities (such as lupus nephritis or sickle cell crisis). The use of stem extensions and cemented fixation optimizes long-term implant stability.

10. Complications

Complications associated with osteonecrosis of the knee and its surgical management are categorized chronologically as immediate, early, and late postoperative events.

11. Pearls and Pitfalls

• Avoid Arthroscopic Pitfalls in Early SPONK: Never perform an isolated arthroscopic partial meniscectomy or chondroplasty for an acute SPONK/SIFK lesion. Resecting meniscal tissue destroys remaining hoop stress protection and accelerates rapid subchondral collapse. Arthroscopy in early SPONK is a major surgical pitfall.
• Scrutinize the Posterior Meniscal Root: In every patient presenting with sudden-onset medial knee pain and medial femoral condyle bone marrow edema, carefully evaluate coronal and sagittal MRI views for a medial meniscus posterior root tear (MMPRT). Identifying root avulsion confirms the mechanical etiology of SIFK.
• The Cardinal Rule of Arthroplasty Selection: Never perform a Unicompartmental Knee Arthroplasty (UKA) for Secondary Osteonecrosis. Secondary ONK is a progressive, multifocal systemic vascular disorder. Placing a UKA in Secondary ONK leads to rapid failure from disease emergence in the lateral compartment, patellofemoral joint, or tibial plateau. UKA is strictly reserved for unicompartmental SPONK/SIFK.
• Verify Subchondral Bone Viability During UKA Resection: When preparing the distal medial femoral condyle and proximal tibia for UKA in SPONK, verify that the bone resection reaches bleeding, viable cancellous bone. If dense, sclerotic, necrotic avascular bone extends deeper than 3 mm to 5 mm beyond standard resections, implant cement interdigitation will fail; convert immediately to Total Knee Arthroplasty.
• Respect the Crescent Sign: Core decompression is contraindicated once a subchondral crescent sign or articular step-off is visible on radiographs. Decompressing a structurally collapsed joint cannot restore articular congruity and accelerates cartilage breakdown.
• Screen for Multifocal Disease in Secondary ONK: In any patient diagnosed with secondary osteonecrosis of the knee associated with corticosteroid exposure or systemic disease, obtain bilateral hip and shoulder radiographs or MRI scans. Multifocal osteonecrosis occurs in over 70% of these individuals.

12. Controversy

Several clinical controversies continue to shape investigation and operative technique in knee osteonecrosis:

• Subchondroplasty versus Core Decompression in Pre-Collapse SIFK: Advocates of subchondroplasty argue that injecting synthetic calcium phosphate bone substitute directly addresses the primary mechanical insufficiency of SIFK by providing immediate structural support to microfractured trabeculae, preventing collapse while allowing osteoconductive incorporation. Critics note that subchondroplasty alters local subchondral compliance, carries risk of extraosseous cement extravasation into the joint space or popliteal fossa, and lacks high-level randomized long-term comparative data compared to simple protected offloading or biological core decompression.
• Unicompartmental Knee Arthroplasty versus Total Knee Arthroplasty for Advanced SPONK: While meta-analyses confirm excellent 10-year survivorship (greater than 94%) for UKA in post-collapse SPONK, debate persists regarding implant selection in elderly patients with borderline cartilage wear in the lateral or patellofemoral compartments. Proponents of UKA highlight superior functional recovery, reduced blood loss, preservation of native knee kinematics, and lower perioperative morbidity. Opponents favor primary TKA to eliminate the risk of revision secondary to late disease progression in adjacent compartments.
• Efficacy of Bisphosphonates in Halting Pre-Collapse SIFK/SPONK: Randomized trials (e.g., Meier et al.) demonstrate that intravenous ibandronate significantly reduces bone marrow lesion volume and prevents subchondral collapse in early SPONK compared to placebo. However, opponents express concern that suppressing osteoclastic remodeling impairs long-term physiological bone turnover, potentially leading to atypical subtrochanteric fractures or osteonecrosis of the jaw, leaving optimal dosing duration and patient selection an active debate.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• C. Meier, C. Kraenzlin, N. F. Friederich et al. Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial. Osteoporosis International. 2014. doi:10.1007/s00198-013-2581-5 [Level I: Randomized Controlled Trial]
• Julio J Jauregui, Christopher L Blum, Neil Sardesai et al. Unicompartmental knee arthroplasty for spontaneous osteonecrosis of the knee: A meta-analysis. Journal of Orthopaedic Surgery. 2018. doi:10.1177/2309499018770925 [Level I: Systematic Review / Meta-Analysis]
• MICHAEL A. MONT, KEITH M. BAUMGARTEN, AIMAN RIFAI et al. Atraumatic Osteonecrosis of the Knee*. The Journal of Bone and Joint Surgery-American Volume. 2000. doi:10.2106/00004623-200009000-00008 [Level IV: Seminal Conceptual Review & Staging Description]
• T Koshino. The treatment of spontaneous osteonecrosis of the knee by high tibial osteotomy with and without bone-grafting or drilling of the lesion. The Journal of Bone & Joint Surgery. 1982. doi:10.2106/00004623-198264010-00008 [Level IV: Seminal Cohort Study & Staging Description]
• PAUL A. LOTKE, JEFFREY A. ABEND, MALCOLM L. ECKER. The Treatment of Osteonecrosis of the Medial Femoral Condyle. Clinical Orthopaedics and Related Research. 1982. doi:10.1097/00003086-198211000-00019 [Level IV: Seminal Case Series & Prognostic Description]

15. Master Class Pro-Tip

The definitive distinction between SPONK (SIFK) and Secondary Osteonecrosis dictates your arthroplasty strategy. When performing unicompartmental knee arthroplasty (UKA) for collapsed SPONK, the procedure succeeds because the pathology is localized mechanical insufficiency rather than systemic osteocyte death. However, intraoperative success hinges on assessing the subchondral resection bed. After completing your standard distal femoral and proximal tibial bone cuts, meticulously inspect the cut surfaces. The bone bed must exhibit brisk cancellous punctate bleeding. If you encounter dense, sclerotic, yellowish avascular bone devoid of bleeding that extends more than 3 to 5 mm deep to your planned resection plane, you cannot rely on methylmethacrylate micro-interdigitation for unicompartmental component fixation. In that scenario, abort the UKA and convert to a primary Total Knee Arthroplasty, utilizing cemented intramedullary stem extensions to bypass the compromised metaphyseal bone and anchor your components securely into healthy diaphysis.

Master Class Surgical Pearl: Distinction Between SPONK and Secondary Osteonecrosis in Arthroplasty Selection